Ignite Creation Date:
2024-05-06 @ 6:15 PM
Last Modification Date:
2024-10-26 @ 2:44 PM
Study NCT ID:
NCT05598814
Status:
RECRUITING
Last Update Posted:
2023-11-30
First Post:
2022-10-25
Brief Title:
Mepolizumab to CRSwNP Through 12 Months - Randomised to FESS and Non-FESS Within the First 2 Weeks
Sponsor:
Vibeke Backer
Organization:
Rigshospitalet Denmark
Organization Data
Organization:
Rigshospitalet Denmark
Class:
OTHER
Study ID:
2022-ENT-FESS-nonFESS
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Vibeke Backer
Lead Sponsor Class:
OTHER
Responsible Party:
Vibeke Backer
Responsible Party Title:
Professor Pulmonologist MD DMSc PI
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Rigshospitalet Denmark
Old Name:
None
Old Organization:
None